36 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
, driven by the core strategy of self-development and global collaboration via in-licensing, asset purchase acquisition etc. Synergizing
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
23 Jan 24
Current report (foreign)
6:49am
of Business Development and Strategy for Perrigo. Mr. Kochan was Vice President, Business Development of Agis Industries (1983) Ltd. ("Agis") from 2001 until
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
30 Nov 23
Current report (foreign)
7:10am
the preventive effect of the medication. Other insights that we are using in our Phase 3 trial design strategy are to pre-screen patients for a specific
6-K
EX-99.1
3s7c2
21 Jun 23
Notice of Annual Meeting of Shareholders
9:38am
6-K
EX-99.1
hw5hhyoe7guk 5jbl1c
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
6-K/A
EX-99.1
mfeb20 1awi31
23 May 22
Notice of Annual Meeting of Shareholders
4:05pm
6-K
EX-99.1
8an7 e8t725msxmr3
19 May 22
Notice of Annual Meeting of Shareholders
4:30pm
424B5
22csdjx5px35
19 Apr 22
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
jj9mi9v
14 Apr 22
Notice of Annual Meeting of Shareholders
4:45pm
20-F/A
de2elx
7 Apr 22
Annual report (foreign) (amended)
4:06pm
6-K
EX-99.2
6u14ika3dm aai1a
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
b8b ipegzxe1
1 Jun 21
Notice of Annual Meeting of Shareholders
2:02pm
6-K
EX-99.1
i4usfj3 mo
18 Feb 21
Current report (foreign)
1:20pm
6-K
EX-99.1
39nbgh
12 Nov 20
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
9:07am